1-8 of 8
Ted Wun, MD, FACP
Close
Sort by
Journal Articles

Effect of Autologous Hematopoietic Stem Cell Transplant (aHSCT) on the Development of Second Primary Malignancies (SPM) in Multiple Myeloma Patients

Aaron Seth Rosenberg, MD, Ann M Brunson, MS, Joseph M Tuscano, MD, Brian A Jonas, MD PhD, Mehrdad Abedi, MD, Ted Wun, MD FACP, FRCPA, Theresa H.M. Keegan, PhD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 332.
https://doi.org/10.1182/blood.V130.Suppl_1.332.332
Published: 2017
Journal Articles

Cancer and Sickle Cell Disease (SCD): Predictors of Incident Cancer and Survival Compared to Non-SCD Patients in California

Ann M Brunson, MS, Theresa H.M. Keegan, PhD MS, Susan T Paulukonis, MA, MPH, Ted Wun, MD FACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 976.
https://doi.org/10.1182/blood.V130.Suppl_1.976.976
Published: 2017
Journal Articles

Changes in Second Primary Malignancies (SPM) after Hodgkin Lymphoma over Time in the United States

Amy Steele, BS, Qian Li, MS, Ann M Brunson, MS, Aaron S. Rosenberg, MD, Ted Wun, MD FACP, FRCPA, Theresa H.M. Keegan, PhD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4097.
https://doi.org/10.1182/blood.V130.Suppl_1.4097.4097
Published: 2017
Journal Articles

a Phase I California Cancer Consortium Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory CD20+ B-Cell Lymphoma; Efficacy, Safety and Immune Correlative Analysis

Joseph Tuscano, MD, Susan Groshen, PhD, Denice Tsao-Wei, Emanual Maverakis, MD, Paul R. Kaesberg, MD, Tanya Siddiqi, MD, Leslie Popplewell**, MD, Sikander Ailawadhi, Myo Htut, Robert W. Chen, MD, Mark Kirschbaum, MD, Mark T. Schroeder, MD, Brian A Jonas, MD PhD, Ted Wun, MD FACP, FRCPA, Neil Palmisiano, MD, David F. Claxton, Edward Newman, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4086.
https://doi.org/10.1182/blood.V130.Suppl_1.4086.4086
Published: 2017
Journal Articles

Predictors Of Vena Cava Filter Use For Venous Thromboembolism In Cancer Patients

Gwendolyn Ho, MD, Ann Brunson, BS, Richard H. White, MD, Ted Wun, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 935.
https://doi.org/10.1182/blood.V122.21.935.935
Published: 2013
Journal Articles

GMI-1070, a Pan-Selectin Inhibitor: Safety and PK In a Phase 1/2 Study In Adults with Sickle Cell Disease

Lori Styles, MD, Ted Wun, MD, FACP, FRCPA, Laura M. De Castro, MD, Marilyn J. Telen, MD, William Kramer, PhD, Henry Flanner, John L Magnani, PhD, Helen Thackray, MD
Journal: Blood
Blood (2010) 116 (21): 1632.
https://doi.org/10.1182/blood.V116.21.1632.1632
Published: 2010
Journal Articles

Identification of Novel Peptide Ligands Targeting α4β1 Integrins on Patient Lymphoma Cells

Harry Tseng, BS, Wenwu Xiao, PhD, Wenzhe Huang, PhD, Ted Wun, MD, FACP, Kit Lam, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4854.
https://doi.org/10.1182/blood.V116.21.4854.4854
Published: 2010
Journal Articles

Effects of Selectin Antagonist GMI-1070 on the Activation State of Leukocytes In Sickle Cell Patients Not In Crisis

Scott I Simon, PhD, Shannon Chase, Sandra K Larkin, Frans Kuypers, Ph.D., Lori Styles, MD, Ted Wun, MD, FACP, Helen Thackray, MD, John L Magnani, PhD
Journal: Blood
Blood (2010) 116 (21): 2672.
https://doi.org/10.1182/blood.V116.21.2672.2672
Published: 2010